AngioDynamics ANGO Business Segments
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| Gross Profit by Business | ||||||
| Med Device | $18.19M-15.4% | $21.5M+7.8% | $19.94M-5.5% | $21.1M+9.5% | $19.27M-2.6% | |
| Med Tech | $23.29M0.0% | $23.29M+6.2% | $21.92M+3.8% | $21.12M+7.8% | $19.59M-2.6% | |
| Cost of sales (exclusive of intangible amortization) by Business | ||||||
| Med Device | $22.95M+3.0% | $22.28M+8.6% | $20.52M-11.8% | $23.27M+8.8% | $21.39M-0.5% | |
| Med Tech | $13.99M+13.1% | $12.37M-7.3% | $13.34M-9.1% | $14.67M+24.8% | $11.75M+2.7% | |
| Gross Margin % by Business | ||||||
| Med Device | 44.2%-4.9pp | 49.1%-0.2pp | 49.3%— | —— | 47.4%-0.5pp | |
| Med Tech | 62.5%-2.8pp | 65.3%+3.1pp | 62.2%— | —— | 62.5%-1.2pp | |
| Net Sales by Product | ||||||
| Med Device | $41.14M-6.0% | $43.78M+8.2% | $40.45M-8.8% | $44.37M+9.1% | $40.66M-1.5% | |
| Med Tech | $37.28M+4.6% | $35.65M+1.1% | $35.26M-1.5% | $35.79M+14.2% | $31.34M-0.7% | |
| Net Sales by Geography | ||||||
| International | $11.15M-5.9% | $11.84M+27.9% | $9.26M-27.0% | $12.67M+18.8% | $10.66M+4.9% | |
| United States | $67.28M-0.5% | $67.59M+1.7% | $66.46M-1.5% | $67.48M+10.0% | $61.34M-2.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does AngioDynamics break its business down?
- AngioDynamics (ANGO) reports gross profit by business across 2 parts — Med Device and Med Tech. Each is extracted from the segment footnotes and tracked over time.
- Where does AngioDynamics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in AngioDynamics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
